Fel-O-Vax LV-K 25's
Fel-O-Vax Lv-K is an inactivated vaccine that protects against Feline Leukaemia Virus (FeLV).
FeLV infects domestic cats throughout the world. Cats at greatest risk include outdoor cats residing in multi-cat environments or cats living with other FeLV-infected cats. The prevalence of infection varies greatly depending on a cat’s age, health, environment, and lifestyle. In the United States, approximately 2 to 3% of all cats are infected with FeLV. Rates rise significantly—13% or more—in cats that are ill, very young, or otherwise at high risk of infection.
Transmission is through transfer of virus in the saliva or nasal secretions resulting from prolonged intimate contact. The virus may also be transmitted by transfusion of blood from an infected cat, in utero, or through the milk. Kittens are the most susceptible to infection; resistance increases with age.
Clinical signs of infection include inappetence, lethargy, weight loss, pale or yellow mucous membranes, vomiting, diarrhoea, reproductive problems, and increased susceptibility to other infections, leukaemia and tumours. Death usually occurs within three years.
The decision to vaccinate an individual cat against FeLV infection should be based on the cat’s age and its risk of exposure. That is, cats not restricted to a closed, FeLV-negative indoor environment. Protection is not induced in all vaccinates, thus making preventing exposure to infected cats the single best way to prevent infection.
If vaccination is deemed appropriate, annual revaccination is recommended. Cats should be tested for FeLV infection before initial vaccination and when there is the possibility that they have been exposed to FeLV since they were vaccinated.
Cats 8 weeks and older. For an initial vaccination course, two doses are required, injected at an interval of three to four weeks.
Booster vaccination. An annual booster of Fel-O-Vax Lv-K vaccine is recommended.
|Indication||An inactivated vaccine for the active immunisation of kittens and cats 10 weeks of age or older against disease caused by feline leukaemia virus.|
|Precautions||Vaccinate only healthy cats or kittens with normal temperatures. Animals under treatment with immunosuppressive drugs should be vaccinated with caution. Studies to support the use of the product in pregnant queens have not been conducted.First Aid Accidental self-injection may lead to an inflammatory response and medical advice should be sought promptly. If possible the application of gentle squeezing pressure with absorbent material (e.g. facial tissues) at the injection site will swab up unabsorbed vaccine. Strong squeezing of the site should be avoided. The damaged area should be thoroughly cleansed and a topical antiseptic applied. If pain persists for more than 12 hours after medical examination, seek medical advice again.|
|Dosage and Administration||Shake the bottle well to obtain a uniform suspension of the vaccine before administration. The entire contents of the bottle should be used immediately after broaching. A new sterile syringe and needle should always be used to administer this vaccine. Dose. 1 mL. Withdraw the contents of a single dose vial (1 mL) aseptically into a sterile syringe and inject intramuscularly (thigh) or subcutaneously. Vaccination program. Fel-O-Vax Lv-K can be used on its own or as part of a standard vaccination program. Cats and kittens 10 weeks and older. Initial vaccination course is two doses injected with a three to four week interval. Booster vaccination. An annual booster with a single dose of vaccine is recommended.|
|Storage||Store at 2 to 8°C. (Refrigerate. Do not freeze.) Protect from light.|
|Manufacturer||Boehringer Ingelheim Animal Health Australia Pty Ltd|